Targeting CD24 for treatment of ovarian cancer by short hairpin RNA

References

• Cannistra SA. Cancer of the ovary. N Engl J Med. 1993; 329:1550–9.
   PubMed Web of Science ®Google Scholar
• Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, et al. Cancer statistics 2005. CA Cancer J. Clin. 2005; 55:10–30.
   PubMed Web of Science ®Google Scholar
• Kristiansen G, Winzer KJ, Mayordomo E, Bellach J, Schlüns K, Denkert C, et al. CD24 expression is a new prognostic marker in breast cancer. Clin Cancer Res. 2003; 9:4906–13.
   PubMed Web of Science ®Google Scholar
• Weichert W, Denkert C, Burkhardt M, Gansukh T, Bellach J, Altevogt P, et al. Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival. Clin Cancer Res. 2005; 11:6574–81.
   PubMed Web of Science ®Google Scholar
• Kristiansen G, Pilarsky C, Wissmann C, Kaiser S, Bruemmendorf T, Roepcke S, et al. Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival. J Pathol. 2005; 205:359–76.
   PubMed Web of Science ®Google Scholar
• Schabath H, Runz S, Joumaa S, Altevogt P. CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells. J Cell Sci. 2006; 119:314–25.
   PubMed Web of Science ®Google Scholar
• Friederichs J, Zeller Y, Hafezi-Moghadam A, Gröne HJ, Ley K, Altevogt P. The CD24/P-selectin binding pathway initiates lung arrest of human A125 adenocarcinoma cells. Cancer Res. 2000; 60:6714–22.
   Google Scholar
• Baumann P, Cremers N, Kroese F, Orend G, Chiquet-Ehrismann R, Uede T, et al. CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis. Cancer Res. 2005; 65:10783–93.
   PubMed Web of Science ®Google Scholar
• Kristiansen G, Denkert C, Schlüns K, Dahl E, Pilarsky C, Hauptmann S. CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival. Am J Pathol. 2002; 161:1215–21.
   PubMed Web of Science ®Google Scholar
• Taguchi T, Kiyokawa N, Mimori K, Suzuki T, Sekino T, Nakajima H. Pre-B cell antigen receptor-mediated signal inhibits CD24-induced apoptosis in human pre-B cells. J Immunol. 2003; 170:252–60.
   PubMedGoogle Scholar
• Smith SC, Oxford G, Wu Z, Nitz MD, Conaway M, Frierson HF, et al. The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancer. Cancer Res. 2006; 66:1917–22.
   PubMedGoogle Scholar
• Yu J-Y, DeRuiter SL, Turner DL. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci USA. 2002; 99:6047–52.
   PubMed Web of Science ®Google Scholar
• Nabel GJ, Nabel EG, Yang Z-Y, Fox BA, Plautz G, Gao X, et al. Direct gene transfer with DNA–liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci USA. 1993; 90:11307–11.
   PubMed Web of Science ®Google Scholar
• Wu Y, Li ZY, Zhao X, Kan B, Wei YQ. Inhibition of ovarian tumor growth by gene therapy with recombinant soluble vascular endothelial growth factor receptor 2. Hum Gene Ther. 2006; 17:941–8.
   Google Scholar
• Li Z, Zhao X, Bai S, Wang Z, Chen L, Wei Y, Huang C. Proteomics identification of cyclophilin A as a potential prognostic factor and therapeutic target in endometrial carcinoma. Mol Cell Proteomics. 2008; 7:1810–23.
   PubMed Web of Science ®Google Scholar
• Fehrmann RS, Li XY, van der Zee AG, de Jong S, Te Meerman GJ, de Vries EG, Crijns AP. Profiling studies in ovarian cancer: a review. Oncologist. 2007; 12:960–6.
   PubMedGoogle Scholar
• Cross D, Burmester JK. Gene therapy for cancer treatment: past, present and future. Clin Med Res. 2006; 4:218–27.
   PubMedGoogle Scholar
• Aigner S, Sthoeger ZM, Fogel M, Weber E, Zarn Jr, Ruppert M, et al. CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood. 1997; 89:3385–95.
   PubMed Web of Science ®Google Scholar
• Pirruccello SJ, Lang MS. Differential expression of CD24-related epitopes in mycosis fungoides/Sezary syndrome. a potential marker for circulating Sezary cells. Blood. 1990; 76:2343–7.
   Google Scholar
• Droz D, Zachar D, Charbit L, Gogusev J, Chretein Y, Iris L. Expression of the human nephron differentiation molecules in renal cell carcinoma. Am J Pathol. 1990; 137:895–905.
   PubMed Web of Science ®Google Scholar
• Jackson D, Waibel R, Weber E, Bell J, Stahel RA. CD24, a signal-transducing molecule expressed on human B cells, is a major surface antigen on small cell lung carcinomas. Cancer Res. 1992; 52:5264–70.
   PubMed Web of Science ®Google Scholar
• Fukushima T, Tezuka T, Shimomura T, Nakano S, Kataoka H. Silencing of insulin-like growth factor-binding protein-2 in human glioblastoma cells reduces both invasiveness and expression of progression-associated gene CD24. J Biol Chem. 2007; 282:18634–44.
   PubMed Web of Science ®Google Scholar
• Chou Y-Y, Jeng Y-M, Lee T-T, Hu F-C, Kao H-L, Lin W-C, et al. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma. Ann Surg Oncol. 2007; 14:2748–58.
   PubMedGoogle Scholar
• Huang L-R, Hsu H-C. Cloning and expression of CD24 gene in human hepatocellular carcinoma: a potential early tumor marker gene correlates with p53 mutation and tumor differentiation. Cancer Res. 1995; 55:4717–21.
   PubMed Web of Science ®Google Scholar
• Gonzalez HE, Gujrati M, Frederick M, Henderson Y, Arumugam J, Spring PW, et al. Identification of 9 genes differentially expressed in head and neck squamous cell carcinoma. Arch Otolaryngol. 2003; 129:754–9.
   Google Scholar
• Yokoyama M, Nishi Y, Yoshii J, Okubo K, Matsubara K. Identification and cloning of neuroblastoma-specific and nerve tissue-specific genes through compiled expression profiles. DNA Res. 1996; 3:311–20.
   Google Scholar
• Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, et al. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian inhibiting substance responsiveness. Proc Natl Acad Sci USA. 2006; 103:11154–9.
   PubMed Web of Science ®Google Scholar
• Smith J, Kontermann RE, Embleton J, Kumar S. Antibody phage display technologies with special reference to angiogenesis. FASEB J. 2005; 19:331–41.
   Google Scholar
• Bodey B, Bodey B Jr, Siegel SE, Kaiser HE. Genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agents. Curr Pharm Des. 2000; 6:261–76.
   PubMed Web of Science ®Google Scholar
• Bertrand JR, Pottier M, Vekris A, Opolon P, Maksimenko A, Malvy C. Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem Biophys Res Commun. 2002; 296:1000–4.
   PubMed Web of Science ®Google Scholar
• Ma HT, On KF, Tsang YH, Poon RYC. An inducible system for expression and validation of the specificity of short hairpin RNA in mammalian cells. Nucleic Acids Res. 2007; 35:e22–
   PubMed Web of Science ®Google Scholar
• Koller E, Propp S, Murray H, Lima W, Bhat B, Prakash TP, et al. Competition for RISC binding predicts in vitro potency of siRNA. Nucleic Acids Res. 2006; 34:4467–76.
   PubMed Web of Science ®Google Scholar
• Hannon GJ, Rossi JJ. Unlocking the potential of the human genome with RNA interference. Nature. 2004; 431:371–8.
   PubMed Web of Science ®Google Scholar
• Haasnoot J, Westerhout EM, Berkhout B. RNA interference against viruses: strike and counterstrike. Nat Biotechnol. 2007; 25:1435–43.
   PubMed Web of Science ®Google Scholar
• Drummond DC, Meyer O, Hong K, Kirpotin DB, Papahadjopoulos D. Optimizing liposomes for delivery of chemo-therapeutic agents to solid tumors. Pharmacol Rev. 1999; 51:691–743.
   PubMed Web of Science ®Google Scholar
• Yuan F, Leunig M, Huang SK, Berk DA, Papahadjopoulos D, Jam RK. Microvascular permeability and interstitial penetration of sterically stabilized (Stealth) liposomes in a human tumor xenograft. Cancer Res. 1994; 54:3352–6.
   PubMed Web of Science ®Google Scholar
• Halder J, Kamat AA, Landen CN, Han L, Lutgendorf SK, Lin YG, et al. Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy. Clin Cancer Res. 2006; 12:4916–24.
   PubMed Web of Science ®Google Scholar
• Lin X, Chen X, Wei Y, Zhao J, Fan L, Wen Y, et al. Efficient inhibition of intraperitoneal human ovarian cancer growth and prolonged survival by gene transfer of vesicular stomatitis virus matrix protein in nude mice. Gynecol Oncol. 2007; 104:540–6.
   Google Scholar
• Harrington KJ, Mohammadtaghi S, Uster PS, Glass D, Peters AM, Vile RG, Stewart JS. Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin Cancer Res. 2001; 7:243–54.
   PubMed Web of Science ®Google Scholar
• Thurston G, McLean JW, Rizen M, Baluk P, Haskell A, Murphy TJ, et al. Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. J Clin Invest. 1998; 101:1401–13.
   PubMed Web of Science ®Google Scholar
• Sagiv E, Starr A, Rozovski U, Khosravi R, Altevogt P, Wang T, Arber N. Targeting CD24 for treatment of colorectal and pancreatic cancer by monoclonal antibodies or small interfering RNA. Cancer Res. 2008; 68:2803–12.
   PubMed Web of Science ®Google Scholar
• Ghobrial IM, Witzig TE, Adjei AA. Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin. 2005; 55:178–94.
   PubMed Web of Science ®Google Scholar
• Sellers WR, Fisher DE. Apoptosis and cancer drug targeting. J Clin Invest. 1999; 104:1655–61.
   PubMed Web of Science ®Google Scholar
• Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA. 1998; 95:4607–12.
   PubMed Web of Science ®Google Scholar
• Rundhaug JE. Matrix metalloproteinases, angiogenesis, and cancer: commentary re: A. C. Lockhart et al., reduction of wound angiogenesis in patients treated with BMS-275291, a broad spectrum matrix metalloproteinase inhibitor. Clin Cancer Res. 2003; 9:551–4.
   PubMed Web of Science ®Google Scholar